GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

93 hedge funds and large institutions have $525M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-22
Holders Change %
-19.13%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
39
Reduced
30
Closed
37
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$669K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$72.2M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$19.7M
3
State Street
3
State Street
Massachusetts
$23.2M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$107M
5
CAM
5
Cormorant Asset Management
Massachusetts
$19M

Top Sellers

1
HIM
1
Hillhouse Investment Management
Cayman Islands
$0
2
EA
2
Emerald Advisers
Pennsylvania
$0
3
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$0
4
DM
4
Deerfield Management
New York
$0
5
MCM
5
Marsico Capital Management
Colorado
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
QT
126
Quantbot Technologies
New York
– -$60K -1,163 Closed
AIM
127
Assured Investment Management
New York
– -$47K -908 Closed
SWP
128
Stratos Wealth Partners
Ohio
– -$16K -300 Closed
PHK
129
Point72 Hong Kong
Hong Kong
– -$15K -294 Closed
TRCT
130
Tower Research Capital (TRC)
New York
– -$4K -80 Closed
MIM
131
Monashee Investment Management
Massachusetts
– -$8.11M – –
2 3 4 5
6